comprehensive -WSS

comprehensive

author：fashion 2025-10-01 18:33:27 - browse：51617

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： ER docs worry over extreme heat as a 'mass casualty event'

explore

WSS

Study: Hearing aids may slow cognitive decline in those at risk

Readout LOUD podcast: Live from the 2023 STAT Summit

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Twill hunts for pharma partner to market its depression app

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Cassava Sciences’ Alzheimer’s clinical trials should be halted

leisure time

comprehensive

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

A look at other Americans who have crossed into North Korea over the years

Psychedelics group wrestles with new pharma identity

UK homeowners get some respite as inflation falls by more than anticipated to a 15

New air purifier tech could be key to improving indoor air quality

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Duchenne breakthrough therapy leaves behind pioneering families

US soldier in North Korean custody after crossing DMZ line

DIEP, the 'gold standard' of breast reconstruction, is under threat

BridgeBio heart drug succeeds in pivotal study

entertainment

UnitedHealth, Optum discontinue NaviHealth name

CZI to create biohub to build anti

Is there really a nursing shortage in the U.S.?

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Questions loom on AstraZeneca cancer drug as safety concerns ebb

entertainment

explore

leisure time

hotspot